Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 1.000 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.529 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.513 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.504 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.496 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.496 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.489 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.489 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.480 | |
| 4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.478 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.478 | |
| 3ict | COA | Coenzyme A disulfide reductase | / | 0.477 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.476 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.475 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.474 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.473 | |
| 3ics | COA | Coenzyme A disulfide reductase | / | 0.472 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.472 | |
| 4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.470 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.470 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.469 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.469 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.468 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.468 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.468 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.466 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.460 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.460 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
| 3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.458 | |
| 4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
| 3beg | ANP | SRSF protein kinase 1 | 2.7.11.1 | 0.457 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.457 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.456 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.456 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.455 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.455 | |
| 2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.454 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.454 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.452 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.450 | |
| 3erk | SB4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.449 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.449 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.449 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.446 | |
| 2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.445 | |
| 4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.444 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.444 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.441 | |
| 2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.441 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.441 | |
| 4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.441 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.440 | |
| 3qa2 | XNA | Ketohexokinase | / | 0.440 | |
| 4b4o | NDP | Epimerase family protein SDR39U1 | / | 0.440 | |
| 4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.440 |